Septerna
Biotechnology company developing oral small molecule therapeutics targeting G protein-coupled receptors using its Native Complex Platform for treating endocrine, metabolic, and immunological disorders.
About
What Septerna is
Biotechnology company developing oral small molecule therapeutics targeting G protein-coupled receptors using its Native Complex Platform for treating endocrine, metabolic, and immunological disorders.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://septerna.com |
| Status coverage | Public status page |
| Founded | 2022 |
| Headquarters | South San Francisco, California, United States |
| Categories | Enterprise, Healthcare |
Loading offerings...